SCOPUS 정보 검색 플랫폼

Volumn 30, Issue 35, 2012, Pages 4447-4448

Frequency of triple-negative breast cancer in BRCA1 mutation carriers: Comparison between common Ashkenazi Jewish and other mutations

(4) Tung, Nadine a Garber, Judy E b Lincoln, Anne c Domchek, Susan M d

a HARVARD MEDICAL SCHOOL (United States)

b DANA FARBER CANCER INSTITUTE (United States)

c BETH ISRAEL DEACONESS MEDICAL CENTER (United States)

d UNIVERSITY OF PENNSYLVANIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ASHKENAZI JEWISH; CANCER GRADING; CANCER PREVENTION; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS;

EID: 84870766773 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2012.44.5635 Document Type: Letter

Times cited : (9)

References (9)

1
- 81755184444
- Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: Results from a population-based study of young women
- Lee E, McKean-Cowdin R, Ma H, et al: Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: Results from a population-based study of young women. J Clin Oncol 29:4373-4380, 2011
- (2011) J Clin Oncol , vol.29 , pp. 4373-4380
- Lee, E.¹ McKean-Cowdin, R.² Ma, H.³

2
- 52049086689
- Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
- Atchley DP, Albarracin CT, Lopez A, et al: Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26:4282-4288, 2008
- (2008) J Clin Oncol , vol.26 , pp. 4282-4288
- Atchley, D.P.¹ Albarracin, C.T.² Lopez, A.³

3
- 72749102465
- Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing
- Evans DG, Lalloo F, Cramer A, et al: Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46:811-817, 2009
- (2009) J Med Genet , vol.46 , pp. 811-817
- Evans, D.G.¹ Lalloo, F.² Cramer, A.³

4
- 84862907494
- Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- Mavaddat N, Barrowdale D, Andrulis IL, et al: Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21:134-147, 2012
- (2012) Cancer Epidemiol Biomarkers Prev , vol.21 , pp. 134-147
- Mavaddat, N.¹ Barrowdale, D.² Andrulis, I.L.³

5
- 12144290945
- Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer: The Influence of Age, Grade, and Histological Type
- DOI 10.1158/1078-0432.CCR-03-1061
- Foulkes WD, Metcalfe K, Sun P, et al: Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: The influence of age, grade, and histological type. Clin Cancer Res 10:2029-2034, 2004 (Pubitemid 38375563)
- (2004) Clinical Cancer Research , vol.10 , Issue.6 , pp. 2029-2034
- Foulkes, W.D.¹ Metcalfe, K.² Sun, P.³ Hanna, W.M.⁴ Lynch, H.T.⁵ Ghadirian, P.⁶ Tung, N.⁷ Olopade, O.I.⁸ Weber, B.L.⁹ McLennan, J.¹⁰ Olivotto, I.A.¹¹ Begin, L.R.¹² Narod, S.A.¹³

6
- 77956032288
- Estrogen receptor positive breast cancers in BRCA1 mutation carriers: Clinical risk factors and pathologic features
- Tung N, Wang Y, Collins LC, et al: Estrogen receptor positive breast cancers in BRCA1 mutation carriers: Clinical risk factors and pathologic features. Breast Cancer Res 12:R12, 2010
- (2010) Breast Cancer Res , vol.12
- Tung, N.¹ Wang, Y.² Collins, L.C.³

7
- 79960834725
- Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women
- Comen E, Davids M, Kirchhoff T, et al: Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women. Breast Cancer Res Treat 129:185-190, 2011
- (2011) Breast Cancer Res Treat , vol.129 , pp. 185-190
- Comen, E.¹ Davids, M.² Kirchhoff, T.³

8
- 77957967823
- Expanding the criteria for BRCA mutation testing in breast cancer survivors
- Kwon JS, Gutierrez-Barrera AM, Young D, et al: Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol 28:4214-4220, 2010
- (2010) J Clin Oncol , vol.28 , pp. 4214-4220
- Kwon, J.S.¹ Gutierrez-Barrera, A.M.² Young, D.³

9
- 77954331064
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
- Hammond ME, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 134:e48-e72, 2010
- (2010) Arch Pathol Lab Med , vol.134
- Hammond, M.E.¹ Hayes, D.F.² Dowsett, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.